Sinopharm requires a third dose for doctors, those over 50 years of age and people at high risk
The Minister of Health of the Nation, Carla Vizzotti has confirmed during a press conference together with the Minister of Tourism, Matías Lammens, that all people over 50 who have been vaccinated with Sinopharm and high-risk groups should receive a third dose.
This will be for people inoculated with any component and over three years old will receive a third dose against immunization against the coronavirus. Likewise, I emphasize that the third injection complements the two previous ones to extend the protection.
These reinforcements will be carried out as of December and the health personnel will be the first to receive them. It is a reinforcement that allows you to increase protection every six months on a regular basis.
Different vaccination points
In the same way, the Minister of Tourism of Argentina Lammens has assured that different inoculation points will be established on the borders of the different provinces with Bolivia; Likewise, tourists who arrive in the country will be able to register to receive the third dose of the vaccine, it is special, for those under 18 years of age.
Argentina's health minister, Vizzotti, said the country averaged 717 daily cases of COVID-19, compared to 1,634 in September and 26,892 in May.
However, the Minister of Health recalled that the number of coronavirus positives increased in adolescents and children, so she considers it very important to be able to advance in the inoculation of these groups to try to stop the advance of the virus.
Argentina received 82,562,985 vaccines, of which 68,696,334 were distributed and 58,553,162 were applied. According to the statements of the Ministry of Health, 72.6% had already started their immunization scheme against the coronavirus, while 55% had already completed it in its entirety.
Therefore, 76% of the Argentine population over 18 years of age already have the two doses of Sinopharm, while in those over 12 years of age it is recorded that at least 68.8% have the doses of this vaccine.